CRP and cancer: A long list of other studies confirmed these findings in different cancer entities and under different clinical scenarios, which established the systemic inflammatory response as a potentially prognostic indicator in cancer patients.115, 116 In addition to the originally used C-reactive protein, a series of other blood-based markers or combinations have been proposed as possible indicators of the systemic inflammatory response.